119 related articles for article (PubMed ID: 34889737)
1. Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression.
Siddharth S; Parida S; Muniraj N; Hercules S; Lim D; Nagalingam A; Wang C; Gyorffy B; Daniel JM; Sharma D
Elife; 2021 Dec; 10():. PubMed ID: 34889737
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct downregulation of MCAM in triple-negative breast cancer cells.
Zeng D; Liang YK; Xiao YS; Wei XL; Lin HY; Wu Y; Bai JW; Chen M; Zhang GJ
Int J Cancer; 2020 Jul; 147(2):490-504. PubMed ID: 32020593
[TBL] [Abstract][Full Text] [Related]
3. FUNDC2, a mitochondrial outer membrane protein, mediates triple-negative breast cancer progression via the AKT/GSK3β/GLI1 pathway.
Yin L; Cao R; Liu Z; Luo G; Li Y; Zhou X; Chen X; Wu Y; He J; Zu X; Shen Y
Acta Biochim Biophys Sin (Shanghai); 2023 Nov; 55(11):1770-1783. PubMed ID: 37700593
[TBL] [Abstract][Full Text] [Related]
4. Identifying Biomarkers Using Support Vector Machine to Understand the Racial Disparity in Triple-Negative Breast Cancer.
Sahoo B; Pinnix Z; Sims S; Zelikovsky A
J Comput Biol; 2023 Apr; 30(4):502-517. PubMed ID: 36716280
[TBL] [Abstract][Full Text] [Related]
5. Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer.
Sirkisoon SR; Carpenter RL; Rimkus T; Anderson A; Harrison A; Lange AM; Jin G; Watabe K; Lo HW
Oncogene; 2018 May; 37(19):2502-2514. PubMed ID: 29449694
[TBL] [Abstract][Full Text] [Related]
6. The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L.
Guarnieri AL; Towers CG; Drasin DJ; Oliphant MUJ; Andrysik Z; Hotz TJ; Vartuli RL; Linklater ES; Pandey A; Khanal S; Espinosa JM; Ford HL
Oncogene; 2018 Jul; 37(28):3879-3893. PubMed ID: 29662198
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females.
Ensenyat-Mendez M; Solivellas-Pieras M; Llinàs-Arias P; Íñiguez-Muñoz S; Baker JL; Marzese DM; DiNome ML
JAMA Netw Open; 2023 Oct; 6(10):e2335821. PubMed ID: 37796506
[TBL] [Abstract][Full Text] [Related]
8. Enhanced immortalization,
Andey T; Attah MM; Akwaaba-Reynolds NA; Cheema S; Parvin-Nejad S; Acquaah-Mensah GK
Gene X; 2020 Dec; 5():100030. PubMed ID: 32550556
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study.
Yaghoobi V; Moutafi M; Aung TN; Pelekanou V; Yaghoubi S; Blenman K; Ibrahim E; Vathiotis IA; Shafi S; Sharma A; O'Meara T; Fernandez AI; Pusztai L; Rimm DL
Breast Cancer Res; 2021 Dec; 23(1):113. PubMed ID: 34906209
[TBL] [Abstract][Full Text] [Related]
10. Sulindac sulfide as a non-immune suppressive γ-secretase modulator to target triple-negative breast cancer.
Hossain F; Ucar DA; Monticone G; Ran Y; Majumder S; Larter K; Luu H; Wyczechowska D; Heidari S; Xu K; Shanthalingam S; Matossian M; Xi Y; Burow M; Collins-Burow B; Del Valle L; Hicks C; Zabaleta J; Golde T; Osborne B; Miele L
Front Immunol; 2023; 14():1244159. PubMed ID: 37901240
[TBL] [Abstract][Full Text] [Related]
11. PLK1 and AURKB phosphorylate survivin differentially to affect proliferation in racially distinct triple-negative breast cancer.
Garlapati C; Joshi S; Bhattarai S; Krishnamurthy J; Turaga RC; Nguyen T; Li X; Aneja R
Cell Death Dis; 2023 Jan; 14(1):12. PubMed ID: 36627281
[TBL] [Abstract][Full Text] [Related]
12. Chromatin Accessibility Landscape of Human Triple-negative Breast Cancer Cell Lines Reveals Variation by Patient Donor Ancestry.
Harris AR; Panigrahi G; Liu H; Koparde VN; Bailey-Whyte M; Dorsey TH; Yates CC; Ambs S
Cancer Res Commun; 2023 Oct; 3(10):2014-2029. PubMed ID: 37732899
[TBL] [Abstract][Full Text] [Related]
13. Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.
Austin D; Hamilton N; Elshimali Y; Pietras R; Wu Y; Vadgama J
Oncotarget; 2018 Sep; 9(74):33912-33930. PubMed ID: 30338035
[TBL] [Abstract][Full Text] [Related]
14. Analysis of gene expression profiles to elucidate racial differences in African American and White patients with Triple-negative breast cancer.
McAndrew H; Rigler J; Yeguvapalli S; Chitrala KN
bioRxiv; 2024 Jun; ():. PubMed ID: 38853921
[TBL] [Abstract][Full Text] [Related]
15. 9S1R nullomer peptide induces mitochondrial pathology, metabolic suppression, and enhanced immune cell infiltration, in triple-negative breast cancer mouse model.
Ali N; Wolf C; Kanchan S; Veerabhadraiah SR; Bond L; Turner MW; Jorcyk CL; Hampikian G
Biomed Pharmacother; 2024 Jan; 170():115997. PubMed ID: 38118350
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiles of triple-negative and luminal A breast cancer subtypes in African-American identify key metabolic differences.
Tayyari F; Gowda GAN; Olopade OF; Berg R; Yang HH; Lee MP; Ngwa WF; Mittal SK; Raftery D; Mohammed SI
Oncotarget; 2018 Feb; 9(14):11677-11690. PubMed ID: 29545929
[TBL] [Abstract][Full Text] [Related]
17. Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in African American and European American patients with TNBC.
Zhu Q; Balasubramanian A; Asirvatham JR; Piyarathna DWB; Kaur J; Mohamed N; Wu L; Chatterjee M; Wang S; Pourfarrokh N; Rasaily U; Xu Y; Zheng J; Jebakumar D; Rao A; Chen SH; Li Y; Chang E; Li X; Aneja R; Zhang XH; Sreekumar A
bioRxiv; 2024 Mar; ():. PubMed ID: 38562769
[TBL] [Abstract][Full Text] [Related]
18. Nullomer peptide increases immune cell infiltration and reduces tumor metabolism in triple negative breast cancer mouse model.
Ali N; Wolf C; Kanchan S; Veerabhadraiah SR; Bond L; Turner MW; Jorcyk CL; Hampikian G
Res Sq; 2023 Jun; ():. PubMed ID: 37461536
[TBL] [Abstract][Full Text] [Related]
19. The LINC01119-SOCS5 axis as a critical theranostic in triple-negative breast cancer.
Tu Z; Schmoellerl J; Mariani O; Zheng Y; Hu Y; Vincent-Salomon A; Karnoub AE
NPJ Breast Cancer; 2021 May; 7(1):69. PubMed ID: 34059683
[TBL] [Abstract][Full Text] [Related]
20. Identification of Distinct Heterogenic Subtypes and Molecular Signatures Associated with African Ancestry in Triple Negative Breast Cancer Using Quantified Genetic Ancestry Models in Admixed Race Populations.
Davis M; Martini R; Newman L; Elemento O; White J; Verma A; Datta I; Adrianto I; Chen Y; Gardner K; Kim HG; Colomb WD; Eltoum IE; Frost AR; Grizzle WE; Sboner A; Manne U; Yates C
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32414099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
